These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 17355733

  • 21. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE, Bochkova AG, Bunchuk NV.
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [Abstract] [Full Text] [Related]

  • 22. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients.
    Burt RK, Georganas C, Schroeder J, Traynor A, Stefka J, Schuening F, Graziano F, Mineishi S, Brush M, Fishman M, Welles C, Rosen S, Pope R.
    Arthritis Rheum; 1999 Nov; 42(11):2281-5. PubMed ID: 10555021
    [Abstract] [Full Text] [Related]

  • 23. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.
    Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T.
    Arthritis Rheum; 2004 Jun; 50(6):1761-9. PubMed ID: 15188351
    [Abstract] [Full Text] [Related]

  • 24. Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.
    Díaz-González F, Alten RH, Bensen WG, Brown JP, Sibley JT, Dougados M, Bombardieri S, Durez P, Ortiz P, de-Miquel G, Staab A, Sigmund R, Salin L, Leledy C, Polmar SH.
    Ann Rheum Dis; 2007 May; 66(5):628-32. PubMed ID: 17170051
    [Abstract] [Full Text] [Related]

  • 25. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 26. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
    Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2007 Sep; 56(9):3096-106. PubMed ID: 17763439
    [Abstract] [Full Text] [Related]

  • 27. Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup.
    Taylor WJ, Rajapakse CN, Harris KA, Harrison AA, Corkill MM.
    J Rheumatol; 1999 Dec; 26(12):2544-50. PubMed ID: 10606361
    [Abstract] [Full Text] [Related]

  • 28. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
    van der Laan W, Molenaar E, Ronday K, Verheijen J, Breedveld F, Greenwald R, Dijkmans B, TeKoppele J.
    J Rheumatol; 2001 Sep; 28(9):1967-74. PubMed ID: 11550961
    [Abstract] [Full Text] [Related]

  • 29. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.
    Bruyn GA, Tate G, Caeiro F, Maldonado-Cocco J, Westhovens R, Tannenbaum H, Bell M, Forre O, Bjorneboe O, Tak PP, Abeywickrama KH, Bernhardt P, van Riel PL, RADD Study Group.
    Ann Rheum Dis; 2008 Aug; 67(8):1090-5. PubMed ID: 18037627
    [Abstract] [Full Text] [Related]

  • 30. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL, Petrov VI, Babayeva AR, Martyushev-Poklad AV, Tcherevkova EV, Epstein OI, Sergeeva SA.
    Int J Tissue React; 2005 Aug; 27(1):15-21. PubMed ID: 15847101
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R.
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [Abstract] [Full Text] [Related]

  • 32. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.
    Paulus HE, Bulpitt KJ, Ramos B, Park G, Wong WK, Western Consortium of Practicing Rheumatologists.
    Arthritis Rheum; 2000 Dec; 43(12):2743-50. PubMed ID: 11145032
    [Abstract] [Full Text] [Related]

  • 33. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO, Bathon J.
    Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
    [Abstract] [Full Text] [Related]

  • 34. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X, Ma J, Tian J, Jiang S, Xu P, Han H, Wang L.
    J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
    [Abstract] [Full Text] [Related]

  • 35. Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis.
    Kanda H, Hamasaki K, Kubo K, Tateishi S, Yonezumi A, Kanda Y, Yamamoto K, Mimura T.
    J Rheumatol; 2002 Sep; 29(9):2024-6. PubMed ID: 12233907
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.
    Dougados M, Emery P, Lemmel EM, de la Serna R, Zerbini CA, Brin S, van Riel P.
    J Rheumatol; 2003 Dec; 30(12):2572-9. PubMed ID: 14719196
    [Abstract] [Full Text] [Related]

  • 37. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis.
    Cibere J, Deng Z, Lin Y, Ou R, He Y, Wang Z, Thorne A, Lehman AJ, Tsang IK, Esdaile JM.
    J Rheumatol; 2003 Mar; 30(3):465-7. PubMed ID: 12610802
    [Abstract] [Full Text] [Related]

  • 38. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial.
    Felson DT, LaValley MP, Baldassare AR, Block JA, Caldwell JR, Cannon GW, Deal C, Evans S, Fleischmann R, Gendreau RM, Harris ER, Matteson EL, Roth SH, Schumacher HR, Weisman MH, Furst DE.
    Arthritis Rheum; 1999 Oct; 42(10):2153-9. PubMed ID: 10524687
    [Abstract] [Full Text] [Related]

  • 39. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial.
    Li EK, Tam LS, Wong CK, Li WC, Lam CW, Wachtel-Galor S, Benzie IF, Bao YX, Leung PC, Tomlinson B.
    Arthritis Rheum; 2007 Oct 15; 57(7):1143-50. PubMed ID: 17907228
    [Abstract] [Full Text] [Related]

  • 40. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis.
    Hamilton SF, Campbell NR, Kara M, Watson J, Connors M.
    J Rheumatol; 2003 Sep 15; 30(9):1948-50. PubMed ID: 12966595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.